CTRI Number |
CTRI/2022/04/041890 [Registered on: 18/04/2022] Trial Registered Prospectively |
Last Modified On: |
21/12/2023 |
Post Graduate Thesis |
No |
Type of Trial |
Interventional |
Type of Study
|
Other (Specify) [Cosmetics] |
Study Design |
Single Arm Study |
Public Title of Study
|
Effect of baby products |
Scientific Title of Study
|
A clinical study to evaluate the safety and efficacy of the baby care products on a healthy pediatric population of the age group 01-36 months. |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
SKIN/MAPS/2022-05 Version 1.0 Dated 24 Mar 2022 |
Protocol Number |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Sharil Hegde |
Designation |
Principal Investigator |
Affiliation |
MS Clinical Research Pvt Ltd |
Address |
Ground floor, Sensitivity room no. 1, 327/15, 1st Main Road Cambridge layout, Ulsoor
Bangalore KARNATAKA 560008 India |
Phone |
08041125934 |
Fax |
08040917253 |
Email |
sharilhegde@yahoo.com |
|
Details of Contact Person Scientific Query
|
Name |
Ritambhara |
Designation |
Director- Business and Operation |
Affiliation |
MS Clinical Research Pvt Ltd |
Address |
Room no.2, Ground floor,327/15, 1st Main Road Cambridge layout, Ulsoor
Bangalore KARNATAKA 560008 India |
Phone |
08041125934 |
Fax |
08040917253 |
Email |
ritambhara@mscr.in |
|
Details of Contact Person Public Query
|
Name |
Sudhanthiran S |
Designation |
Study Manager |
Affiliation |
MS Clinical Research Pvt Ltd |
Address |
First Floor, Room no. 1, Councelling Area, 327/15, 1st main road, cambridge layout, ulsoor
Bangalore KARNATAKA 560008 India |
Phone |
08041125934 |
Fax |
08040917253 |
Email |
sudhan@mscr.in |
|
Source of Monetary or Material Support
|
Marico Limited Marks, plot no:23-C Mahal, Industrial Estate Mahakali Caves Road, Andheri(E), Mumbai 400093 |
|
Primary Sponsor
|
Name |
Marico Limited |
Address |
Marks, plot no:23-C Mahal, Industrial Estate Mahakali Caves Road, Andheri(E), Mumbai 400093 |
Type of Sponsor |
Other [FMCG(Fast moving Consumer Goods)] |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Sharil Hegde |
MS Clinical Research Pvt. Ltd. |
Ground floor, Sensitivity room No. 1 ,327/15, 1st Main Road Cambridge layout, Ulsoor Bangalore KARNATAKA |
08041125934 08040917253 sharilhegde@yahoo.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Clinicom Ethics Committee |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Healthy Human Volunteers |
Healthy Pediatric population of the age group 01 to 36 months |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Comparator Agent |
None |
NA |
Intervention |
RM.M480.67 |
Gently massage onto damp skin before bathing, after bathing and before night sleep. Duration - 28 days |
|
Inclusion Criteria
|
Age From |
1.00 Month(s) |
Age To |
36.00 Month(s) |
Gender |
Both |
Details |
1. Subjects in the age group 1-12 months, 12-24 months and 24-36 months in nearly equal ratio (both genders inclusive)
2. Subjects in general good health as determined from a recent medical history
3. Subject’s mother/authorized legal representative, preferably mother willing to give a voluntary written informed consent and agree to come for regular follow up.
4. Subject’s mother/authorized legal representative, preferably mother willing to abide by and comply with the study protocol.
5. Subject’s mother/legal representative agreeing not to use any other product of the same nature and change any habit or other regular products during the study period. |
|
ExclusionCriteria |
Details |
1. A known history or present condition or any other concern that may require medical attention
2. Subejcts deemed unfit to participate in the study based on the general health and hygiene.
3. Babies whose parents and/or authorized legal guardian are not willing to sign the informed consent. |
|
Method of Generating Random Sequence
|
Not Applicable |
Method of Concealment
|
Case Record Numbers |
Blinding/Masking
|
Open Label |
Primary Outcome
|
Outcome |
TimePoints |
1.To evaluate the safety and efficacy of test products on a pediatric population by one month home use test in comparison to the baseline.
2. To evaluate the skin health and quality by dermatological assessment and instrumental evaluation in comparison to the baseline. |
4 weeeks |
|
Secondary Outcome
|
Outcome |
TimePoints |
None |
NA |
|
Target Sample Size
|
Total Sample Size="38" Sample Size from India="38"
Final Enrollment numbers achieved (Total)= "37"
Final Enrollment numbers achieved (India)="37" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
18/04/2022 |
Date of Study Completion (India) |
06/10/2022 |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Date Missing |
Estimated Duration of Trial
|
Years="0" Months="2" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
Recruitment Status of Trial (India) |
Completed |
Publication Details
|
Nil |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
Study will be conducted to assess the safety and efficacy of the test products. After consenting and qualifying the inclusion and exclusion criteria subjects will be enrolled into the study. For the selected subjects, the test products will be dispensed for the usage of 28 days. The assessment will be performed for week 1, 2 and 4. |